← Evidence map

ReviewDrugs2019

Dapagliflozin: A Review in Type 2 Diabetes.

Sohita DhillonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

113 papers cite itlatest 60 shown

2019
…
2022
2024
2025
2026
this paperpooled ittrialcites it

The trial

NCT05565976phase 2/phase 3270 enrolled2020
Full record →Abstract, authors, funding and every citing paper · PMID 31236801